Assertion Supported AI assessment confidence: 95% certainty 4/5 debate potential 2/5

Bisignano: Most genetic research is based on European and Jewish populations

Alexander Bisignano · Alexander Bisignano, Recombine // Genetic Testing // Data Driven NYC (FirstMark Capital) · Feb 18, 2015 · at 13:02

Alexander Bisignano, CEO of Recombine, explains population bias in existing genomic literature during a talk at Data Driven NYC.

0:00 / 0:08exact quote · 8.6s

▶ Watch the full episode on YouTube → 720p mp4 · rendered on demand · StarZero watermark

“Most of genetics actually is based on studying European and Jewish individuals just because that's been the body of literature that's been developed over the past few decades.”

quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →

The claim, plainly

Most historical genetic research literature is based on studying European and Jewish populations.

a quote alone can be ambiguous, so this restates it with the references and context of the conversation around it resolved. AI-written; the tape below the player is the source.

Assessment

Meta-analyses and systematic reviews of genomic research databases published prior to 2015, such as Need & Goldstein (2009) and Bustamante et al. (2011) in Nature, confirmed that 96% of all participants in published genome-wide association studies (GWAS) were of European descent. Historically, Ashkenazi Jewish populations were also extensively studied for specific genetic disorders and typically categorized within European ancestry cohorts in these databases. Consequently, European and Jewish populations comprised the vast majority of participants in the genetic research literature up to 2015.

Need & Goldstein (2009) showed that 96% of participants in published GWAS were of European descent.
Bustamante et al. (2011) in Nature confirmed that 96% of subjects in published GWAS remained individuals of European descent.

Checked against

[1] nih.gov [2] ovid.com [3] nih.gov [4] nih.gov [5] jewishgenetics.org [6] jscreen.org [7] jnetics.org [8] 23andme.org

"European and Jewish" genetic research literature OR "European and Jewish" genomics genomics diversity European Ashkenazi Jewish participants GWAS catalog 2009 2011 2014 GWAS catalog diversity European ancestry Need Goldstein 2009 Bustamante Nature 2011 genomics for the world European ancestry percentage genomic research literature European Jewish populations bisignano "Ashkenazi Jewish" founder population genetic studies history dominant

assessed as of 2026-07-30

This assessment is an AI reading of a public statement, made against the cited references with the confidence shown. It can be wrong. The quote, the tape and the references are all on this page; if something is off, use report an error below. full disclaimer →

Mentioned

European and Jewish individuals genetics literature

⚑ Spot an error? Report it

More from Alexander Bisignano

Assertion Partly supported

Bisignano: Science has not truly sequenced the entire human genome

“We actually haven't truly sequenced the whole human genome just because there's so much variation that we can't capture yet.”

Alexander Bisignano Feb 18, 2015 ▶ 13:49 Alexander Bisignano, Recombine // Genetic Testing // Data Driven NYC (FirstMark Capital)

Opinion

Bisignano: LabCorp and Quest hold an oligopoly on insurance contracts

“LabCorp and Quest have sort of an oligopoly on insurance contracts, and people tend to stay in network.”

Alexander Bisignano Feb 18, 2015 ▶ 21:02 Alexander Bisignano, Recombine // Genetic Testing // Data Driven NYC (FirstMark Capital)

Opinion

Bisignano: Major diagnostic companies Quest and LabCorp lack agile software teams

“Most laboratory diagnostic companies are not set up as software companies. Example, Quest and LabCorp. Two largest companies in the country that do laboratory testing. Twelve billion dollar market cap. They are not agile software teams.”

Alexander Bisignano Feb 18, 2015 ▶ 4:55 Alexander Bisignano, Recombine // Genetic Testing // Data Driven NYC (FirstMark Capital)

Assertion Not checkable as stated

Bisignano: Recombine achieves over 65% patient opt-in rate for research

“We see a 65% or more opt-in from most of the centers”

Alexander Bisignano Feb 18, 2015 ▶ 19:08 Alexander Bisignano, Recombine // Genetic Testing // Data Driven NYC (FirstMark Capital)

Assertion Contradicted

Bisignano: Human genome sequencing costs fell from $3B to $1,000

“We finished the human genome, and then for the next decade, the human genome, the cost to sequence it went from three billion down to 1000.”

Alexander Bisignano Feb 18, 2015 ▶ 4:16 Alexander Bisignano, Recombine // Genetic Testing // Data Driven NYC (FirstMark Capital)

Assertion Contradicted

Bisignano: US has one genetic counselor per 250,000 people

“Right now there's about one genetic counselor for every 250,000 individuals in the U.S.”

Alexander Bisignano Feb 18, 2015 ▶ 8:27 Alexander Bisignano, Recombine // Genetic Testing // Data Driven NYC (FirstMark Capital)

Bisignano: Most genetic research is based on European and Jewish populations

More from Alexander Bisignano

Turn any episode into a week of clips.